...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: " Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."

" Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."

posted on May 09, 2022 07:47AM

must be seeing some good/great things??

Share
New Message
Please login to post a reply